Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients

Journal of Neuroscience Research

Volumn 94, Issue 12, 2016, Pages 1579-1587

  Moyano, Ana Lis ^a   Li, Guannan ^b   Boullerne, Anne I ^a   Feinstein, Douglas L ^a,c   Hartman, Elizabeth ^d   Skias, Demetrios ^b   Balavanov, Roumen ^e   van Breemen, Richard B ^b   Bongarzone, Ernesto R ^a   Månsson, Jan Eric ^f   Givogri, Maria I ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d Center for Neurosciences Orthopedics and Spine   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

biomarker; extracellular vesicles; multiple sclerosis; plasma vesicles; sulfatides

Indexed keywords

ALIX PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MARKER; RAB 5B PROTEIN; SULFATIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; NANOPARTICLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PARTICLE SIZE; PLASMA; PRIORITY JOURNAL; PROTEIN CONTENT; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; CHEMISTRY; CYTOPLASM VESICLE; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; YOUNG ADULT;

ADULT; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOPLASMIC VESICLES; EXTRACELLULAR VESICLES; FEMALE; GENES, MHC CLASS I; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NANOPARTICLES; PARTICLE SIZE; SULFOGLYCOSPHINGOLIPIDS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84991714525     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23899     Document Type: Article

References (49)

1. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341–345.
2. Barral DC, Brenner MB. 2007. CD1 antigen presentation: how it works. Nat Rev Immunol 7:929–941.
3. Blomqvist M, Rhost S, Teneberg S, Lofbom L, Osterbye T, Brigl M, Mansson JE, Cardell SL. 2009. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur J Immunol 39:1726–1735.
4. Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, Ostrowski M, Thery C. 2012. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 72:4920–4930.
5. Candelario KM, Steindler DA. 2014. The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends Mol Med 20:368–374.
6. Carandini T, Colombo F, Finardi A, Casella G, Garzetti L, Verderio C, Furlan R. 2015. Microvesicles: what is the role in multiple sclerosis? Front Neurol 6:111.
7. Colombo M, Raposo G, Thery C. 2014. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–289.
8. Compston A, Coles A. 2008. Multiple sclerosis. Lancet 372:1502–1517.
9. Deng ZB, Ju S, Zhuang X, Xiang X, Mu J, Liu Y, Hong J, Zhang L, Mobley J, McClain C, Feng W, Grizzle W, Yan J, Miller D, Kronenberg M, Zhang HG. 2013. Exosomes-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver natural killer T cells. J Immunol 190:3579–3589.
10. Gatson NN, Williams JL, Powell ND, McClain MA, Hennon TR, Robbins PD, Whitacre CC. 2011. Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors. J Neuroimmunol 230:105–113.
11. Gehrmann U, Hiltbrunner S, Georgoudaki AM, Karlsson MC, Naslund TI, Gabrielsson S. 2013. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with alpha-galactosylceramide on exosomes. Cancer Res 73:3865–3876.
12. Haghighi S, Lekman A, Nilsson S, Blomqvist M, Andersen O. 2013. Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients. J Neurol Sci 326:35–39.
13. Han M, Jun SH, Song SH, Park HD, Park KU, Song J. 2014. Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy. Rapid Commun Mass Spectrom 28:587–594.
14. Harris VK, Sadiq SA. 2014. Biomarkers of therapeutic response in multiple sclerosis: current status. Mol Diagn Ther 18:605–617.
15. Ishizuka I. 1997. Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 36:245–319.
16. Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V. 2004. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 199:947–957.
17. Jimenez J, Jy W, Mauro LM, Horstman LL, Ahn ER, Ahn YS, Minagar A. 2005. Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Mult Scler 11:310–315.
18. Kanninen KM, Bister N, Koistinaho J, Malm T. 2016. Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta 1862:403–410.
19. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Thery C. 2016. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A 113:E968–E977.
20. Kramer-Albers EM, Bretz N, Tenzer S, Winterstein C, Mobius W, Berger H, Nave KA, Schild H, Trotter J. 2007. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons? Proteomics Clin Appl 1:1446–1461.
21. Kwiecinski J, Rhost S, Lofbom L, Blomqvist M, Mansson JE, Cardell SL, Jin T. 2013. Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway. Infect Immun 81:1114–1120.
22. Laulagnier K, Grand D, Dujardin A, Hamdi S, Vincent-Schneider H, Lankar D, Salles JP, Bonnerot C, Perret B, Record M. 2004. PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett 572:11–14.
23. Llorente A, Skotland T, Sylvanne T, Kauhanen D, Rog T, Orlowski A, Vattulainen I, Ekroos K, Sandvig K. 2013. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta 1831:1302–1309.
24. Logozzi M, De Milito A, Lugini L, Borghi M, Calabrò L, Spada M, Perdicchio M, Marino ML, Federici C, Iessi E, Brambilla D, Venturi G, Lozupone F, Santinami M, Huber V, Maio M, Rivoltini L, Fais S. 2009. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 4:e5219.
25. Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR. 2015. Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS One. 10:e0139233
26. Maricic I, Halder R, Bischof F, Kumar V. 2014. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis. J Immunol 193:1035–1046.
27. Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, Molle N, Mathews SA, Gao B, Kumar V. 2015. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology 61:1357–1369.
28. Moyano AL, Pituch K, Li G, van Breemen R, Mansson JE, Givogri MI. 2013. Levels of plasma sulfatides C18 : 0 and C24 : 1 correlate with disease status in relapsing-remitting multiple sclerosis. J Neurochem. 127:600–604
29. Muindi K, Cernadas M, Watts GF, Royle L, Neville DC, Dwek RA, Besra GS, Rudd PM, Butters TD, Brenner MB. 2010. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d. Proc Natl Acad Sci U S A 107:3052–3057.
30. Mycko MP, Sliwinska B, Cichalewska M, Cwiklinska H, Raine CS, Selmaj KW. 2014. Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination. J Neurosci 34:8646–8658.
31. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. 2011. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302.
32. Rajendran L, Bali J, Barr MM, Court FA, Kramer-Albers EM, Picou F, Raposo G, van der Vos KE, van Niel G, Wang J, Breakefield XO. 2014. Emerging roles of extracellular vesicles in the nervous system. J Neurosci 34:15482–15489.
33. Record M, Carayon K, Poirot M, Silvente-Poirot S. 2014. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta 1841:108–120.
34. Roeske-Nielsen A, Fredman P, Mansson JE, Bendtzen K, Buschard K. 2004. Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. Immunol Lett 91:205–211.
35. Roy KC, Maricic I, Khurana A, Smith TR, Halder RC, Kumar V. 2008. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells. J Immunol 180:2942–2950.
36. Saenz-Cuesta M, Irizar H, Castillo-Trivino T, Munoz-Culla M, Osorio-Querejeta I, Prada A, Sepulveda L, Lopez-Mato MP, Lopez de Munain A, Comabella M, Villar LM, Olascoaga J, Otaegui D. 2014. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomark Med 8:653–661.
37. Serna J, Garcia-Seisdedos D, Alcazar A, Lasuncion MA, Busto R, Pastor O. 2015. Quantitative lipidomic analysis of plasma and plasma lipoproteins using MALDI-TOF mass spectrometry. Chem Phys Lipids 189:7–18.
38. Sheremata WA, Jy W, Delgado S, Minagar A, McLarty J, Ahn Y. 2006. Interferon-beta1a reduces plasma CD31 + endothelial microparticles (CD31+EMP) in multiple sclerosis. J Neuroinflammation 3:23.
39. Sodar BW, Kittel A, Paloczi K, Vukman KV, Osteikoetxea X, Szabo-Taylor K, Nemeth A, Sperlagh B, Baranyai T, Giricz Z, Wiener Z, Turiak L, Drahos L, Pallinger E, Vekey K, Ferdinandy P, Falus A, Buzas EI. 2016. Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Sci Rep 6:24316.
40. Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, Paillasse M, De Medina P, Monsarrat B, Perret B, Silvente-Poirot S, Poirot M, Record M. 2010. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res 51:2105–2120.
41. Subramanian L, Blumenfeld H, Tohn R, Ly D, Aguilera C, Maricic I, Mansson JE, Buschard K, Kumar V, Delovitch TL. 2012. NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice. PLoS One 7:e37771.
42. Takahashi T, Suzuki T. 2012. Role of sulfatide in normal and pathological cells and tissues. J Lipid Res 53:1437–1450.
43. Thery C, Amigorena S, Raposo G, Clayton A. 2006. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3:Unit 3.22.
44. Tkach M, Thery C. 2016. Communication by extracellular vesicles: where we are and where we need to go. Cell 164:1226–1232.
45. Trapp BD, Nave KA. 2008. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269.
46. Turpin D, Truchetet ME, Faustin B, Augusto JF, Contin-Bordes C, Brisson A, Blanco P, Duffau P. 2016. Role of extracellular vesicles in autoimmune diseases. Autoimmun Rev 15:174–183.
47. Van Kaer L, Wu L, Parekh VV. 2015. Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. Immunology 146:1–10.
48. Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, Riganti L, Corradini I, Francolini M, Garzetti L, Maiorino C, Servida F, Vercelli A, Rocca M, Dalla Libera D, Martinelli V, Comi G, Martino G, Matteoli M, Furlan R. 2012. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann Neurol 72:610–624.
49. Westphal M, Lamszus K. 2015. Circulating biomarkers for gliomas. Nat Rev Neurol 11:556–566.